Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of New Serum Biomarkers of Ferroptosis in Patients With COPD With/Without Risk of Cardiovascular Events. Pathophysiological Implications, Diagnostics and Prognoses. FerrEPOC Study

NCT06102993 is registered in ClinicalTrials.gov with Hospital Universitario Marqués de Valdecilla as lead sponsor.

NCT NCT06102993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06102993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of New Serum Biomarkers of Ferroptosis in Patients With COPD With/Without Risk of Cardiovascular Events. Pathophysiological Implications, Diagnostics and Prognoses. FerrEPOC Study
Lead sponsor
Hospital Universitario Marqués de Valdecilla
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2023
Completion date
October 1, 2025
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation